Kalaris Therapeutics, Inc. (KLRS) — Insider Trading
Insider trading activity for Kalaris Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.
Overview
- Total insider trades: 5
- Last trade date: Mar 23, 2026
- Ticker: KLRS
Top Insiders
- Oxtoby Andrew (See Remarks) — 1 trades, buy: $0, sell: $0
- Gall Matthew (Chief Financial Officer) — 1 trades, buy: $0, sell: $0
- Feinsod Matthew (Chief Medical Officer) — 1 trades, buy: $0, sell: $0
- Hagen Brett R (Chief Accounting Officer) — 2 trades, buy: $0, sell: $13K
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Hagen Brett R | KLRS Kalaris Therapeutics, Inc. | BUY | 60,800 | N/A |
| Mar 20, 2026 | Hagen Brett R | KLRS Kalaris Therapeutics, Inc. | SELL | 1,915 | $13K |
| Mar 19, 2026 | Feinsod Matthew | KLRS Kalaris Therapeutics, Inc. | BUY | 135,000 | N/A |
| Mar 19, 2026 | Gall Matthew | KLRS Kalaris Therapeutics, Inc. | BUY | 95,000 | N/A |
| Mar 19, 2026 | Oxtoby Andrew | KLRS Kalaris Therapeutics, Inc. | BUY | 222,000 | N/A |